Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A clinical and molecular pathology prediction model for central lymph node metastasis in cN0 papillary thyroid microcarcinoma. | Front Endocrinol (Lausanne) | 2023 | 36817603 | PubTator, text mining | PubMed |
| Baicalin Inhibits Airway Smooth Muscle Cells Proliferation through the RAS Signaling Pathway in Murine Asthmatic Airway Remodeling Model. | Oxid Med Cell Longev | 2023 | 36814956 | PubTator, text mining | PubMed |
| Rare molecular subtypes of lung cancer. | Nat Rev Clin Oncol | 2023 | 36806787 | PubTator, text mining | PubMed |
| Structure and function of microbial α-l-fucosidases: a mini review. | Essays Biochem | 2023 | 36805644 | PubTator, text mining | PubMed |
| BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. | NPJ Precis Oncol | 2023 | 36801912 | PubTator, text mining | PubMed |
| i-Motif folding intermediates with zero-nucleotide loops are trapped by 2'-fluoroarabinocytidine via F···H and O···H hydrogen bonds. | Commun Chem | 2023 | 36797370 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action. | Chin Med | 2023 | 36782251 | PubTator, text mining | PubMed |
| Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling. | Molecules | 2023 | 36770611 | PubTator, text mining | PubMed |
| Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus. | Int J Mol Sci | 2023 | 36768940 | PubTator, text mining | PubMed |
| Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study. | Int J Mol Sci | 2023 | 36768623 | PubTator, text mining | PubMed |
| Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature. | Cells | 2023 | 36766791 | PubTator, text mining | PubMed |
| ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. | Cancers (Basel) | 2023 | 36765910 | PubTator, text mining | PubMed |
| MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. | Cancers (Basel) | 2023 | 36765665 | PubTator, text mining | PubMed |
| An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. | Cancer Inform | 2023 | 36762284 | PubTator, text mining | PubMed |
| BRAF RNA is prognostic and widely expressed in lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 36762067 | PubTator, text mining | PubMed |
| Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations. | Acta Haematol | 2023 | 36754028 | PubTator, text mining | PubMed |
| Developing SHP2-based combination therapy for KRAS-amplified cancer. | JCI Insight | 2023 | 36752207 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| Inferring cancer common and specific gene networks via multi-layer joint graphical model. | Comput Struct Biotechnol J | 2023 | 36733706 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=14